Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. 5000363102

Medchemexpress LLC Apilimod | 541550-19-0 | 99.8% | 418.49 | 200 MG
SDP

Catalog No. 5000363102
Encompass_Preferred

Apilimod is a potent IL-12/IL-23 inhibitor, strongly inhibiting IL-12 with IC50s of 1 nM and 2 nM in IFN-γ/SAC-stimulated human PBMCs and SAC-treated monkey PBMCs, respectively. It is also described as a potent and highly selective PIKfyve inhibitor.

  • Potent IL-12/IL-23 inhibitor
  • Strongly inhibits IL-12 with IC50s of 1 nM and 2 nM
  • Potent and highly selective PIKfyve inhibitor
  • Inhibits IFN-γ production in human PBMCs
  • Reduces severity of experimental autoimmune uveoretinitis (EAU)
  • Lowers level of IL-12 p40 in serum without altering body weight in EAU mice
  • Effective in Th1 model, with 51%±8% inhibition

Catalog No. 50-003-63102 Supplier Medchemexpress LLC Supplier No. HY14644200MG
May include imposed supplier surcharges.
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

Apilimod is a potent IL-12/IL-23 inhibitor, strongly inhibiting IL-12 with IC50s of 1 nM and 2 nM in IFN-γ/SAC-stimulated human PBMCs and SAC-treated monkey PBMCs, respectively. It is also described as a potent and highly selective PIKfyve inhibitor.

  • Potent IL-12/IL-23 inhibitor
  • Strongly inhibits IL-12 with IC50s of 1 nM and 2 nM
  • Potent and highly selective PIKfyve inhibitor
  • Inhibits IFN-γ production in human PBMCs
  • Reduces severity of experimental autoimmune uveoretinitis (EAU)
  • Lowers level of IL-12 p40 in serum without altering body weight in EAU mice
  • Effective in Th1 model, with 51%±8% inhibition

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.